2008
- Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells (May 8, 2008)
- WARF Licenses Influenza Vaccine Technology to FluGen, Start-up Company Founded by UW-Madison Inventor Kawaoka (May 8, 2008)
- Roche NimbleGen CEO Rose Speaks on Successful Exit Strategies for Start-up Companies at WARF's Gilson Series (Apr 24, 2008)
- Association of University Technology Managers Honors WARF's Andrew Cohn (Mar 31, 2008)
- TomoTherapy's Mackie Speaks on Faculty Entrepreneurship at WARF's Gilson Series (Mar 28, 2008)
- WARF, UW-Madison Influenza Researcher and Lentigen Agree to Donate Technology to Ensure Global Access to Avian Influenza Monitoring Methods (Mar 25, 2008)
- Patent Office Upholds Remaining WARF Stem Cell Patents (Mar 11, 2008)
- United States Patent and Trademark Office Upholds Key WARF Stem Cell Patent (Feb 28, 2008)
- Gilson Event Highlights Conflicts of Interest in Clinical Trials (Feb 27, 2008)
- Faculty Entrepreneurs Discuss Conflicts of Interest at WARF Gilson Discovery Series (Feb 13, 2008)
- WARF Charges Intel Corporation with Patent Infringement of UW-Madison Invention That Speeds Computer Processing (Feb 6, 2008)
- California Company Licenses Human Embryonic Stem Cell Technology from WARF (Jan 9, 2008)
2006
2005
2004
2003
2002
2001
2000
